LOS ANGELES, May 7, 2019 /PRNewswire/ — Zynx Health™, market leader in providing evidence- and experience-based clinical improvement solutions since 1996, today announced that Dr. Howard Willson has joined the company as Senior Vice President of Customer Success. In this role, Willson will lead customer satisfaction initiatives that deliver maximum value to Zynx Health clients.
“Dr. Willson’s wide-ranging healthcare experience makes him an excellent addition to the Zynx team,” said Kevin Daly, president of Zynx Health. “We will take advantage of his strong operational and clinical background to advance the development of solutions that help clients achieve their strategic goals. I am confident that our clients will benefit from his commitment to connecting users with clinical solutions that deliver an exemplary customer experience.”
Over the past 20 years, Willson has worked in clinical operations on the hospital side, as well as consumerism on the employer side. Prior to Zynx Health, he was the head of clinical strategy at Castlight Health, a San Francisco–based public company that pioneered healthcare transparency and decision support for consumers. While at Castlight, Willson led the clinical development for most of the organization’s health navigation products.
Prior to joining Castlight, Willson served as department chief of emergency medicine at Swedish Medical Center in Seattle, the largest health system in the Pacific Northwest. He is also co-founder of a company that developed an automated process for emergency department facility coding. Willson holds an MD from the University of Illinois College of Medicine, an MBA from The Wharton School, and a BA from Dartmouth College.
“Zynx has a long history of partnering with healthcare professionals to deliver clinical solutions that advance quality care and financial performance and improve the health of patients,” said Willson. “I am excited be part of the Zynx team and to work with clients developing strategies and solutions that drive clinical excellence across their organizations.”
About Zynx Health
Zynx Health, part of the Hearst Health network, provides healthcare professionals with vital information and processes that guide care decisions and reduce complexity across the entire patient journey in a way that leads to healthier lives for all. Zynx is a pioneer and market leader in evidence- and experience-based clinical solutions that help health systems improve patient outcomes, financial outcomes, clinical engagement, and technology performance. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models. To learn more, visit zynxhealth.com or call 888.996.9435.
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 77 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MHK (formerly MedHOK—Medical House of Knowledge) and Hearst Health Ventures (www.hearsthealth.com). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth or LinkedIn @Hearst-Health.
Media Contact: |
Zynx Health Contact: |
Michelle Ronan Noteboom |
Michelle McCabe |
Amendola Communications |
Senior Director, Commercial Operations & Marketing |
512.426.2870 |
407.902.7712 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/zynx-health-appoints-dr-howard-willson-senior-vice-president-of-customer-success-300844922.html
SOURCE Zynx Health
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…